Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C.
Perrillo R, Rothstein KD, Rubin R, Alam I, Imperial J, Harb G, Hu S, Klaskala W. Perrillo R, et al. Among authors: klaskala w. J Viral Hepat. 2004 Mar;11(2):157-65. doi: 10.1046/j.1365-2893.2003.00482.x. J Viral Hepat. 2004. PMID: 14996351 Clinical Trial.
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
Sullivan SD, Jensen DM, Bernstein DE, Hassanein TI, Foster GR, Lee SS, Cheinquer H, Craxi A, Cooksley G, Klaskala W, Pettit K, Patel KK, Green J. Sullivan SD, et al. Among authors: klaskala w. Am J Gastroenterol. 2004 Aug;99(8):1490-6. doi: 10.1111/j.1572-0241.2004.30286.x. Am J Gastroenterol. 2004. PMID: 15307866
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page